Mazzara Philip's Form 4/A amendment
AmendedAstera Labs, Inc. (ALAB) · filed Aug 28, 2024
- Accession no.
- 0001736297-24-000025
- Filed
- Aug 28, 2024
- Trade date
- Aug 23-26, 2024
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Aug 26, 2024
This filing lists 5 non-derivative transactions. Open-market sales total $2.04M. It was filed 5 days after the trade.
This amendment replaces 0001736297-24-000024 (filed Aug 26, 2024).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mazzara PhilipCIK 0001998163 | Officer (General Counsel and Secretary) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 23, 2024 | Common Stock | SSaleDisposed | −12,188 | $39.72F2 | −$484,107.36 | 363,376 | Direct | |
| Aug 23, 2024 | Common Stock | SSaleDisposed | −19,355 | $40.28F3 | −$779,619.4 | 344,021 | Direct | |
| Aug 23, 2024 | Common Stock | SSaleDisposed | −10,457 | $41.52F4 | −$434,174.64 | 333,564 | Direct | |
| Aug 26, 2024 | Common Stock | SSaleDisposed | −1,600 | $42.62F5 | −$68,192 | 331,964 | Direct | |
| Aug 26, 2024 | Common Stock | SSaleDisposed | −6,400 | $43.25F6 | −$276,800 | 325,564 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on May 24, 2024.
- F2
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.96 to $39.95. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.96 to $40.94. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.98 to $41.86. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.81 to $42.80. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F6
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.90 to $43.81. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
Remarks
This form 4 Amendment is being filed to reflect the final number of shares reported in Table I, Row 3, Column 4 of the Reporting Person's Form 4 filed on August 26, 2024.